Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.
The vector of anti-EBVgp350 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target EBV EBVgp350. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-EBVgp350 antibody linked to CD28 and CD3_ signaling domains. And the vector product was designed for the treatment of Pancreatic cancer.
Creative Biolabs is the leading custom service provider with extensive experience in various antibody production and engineering fields.